论文部分内容阅读
近年来气溶疗法在呼吸系统疾患上的应用极为广泛,如慢性支气管炎,支气管扩张,肺脓肿,以及支气管哮喘,支气管内膜结核等等,均用药物气溶吸入,在临床上获得显著疗效。气溶疗法的雾滴大小对吸入后到达之部位,一般均有记载,如雾化颗粒大小在10—30微米,可达到上呼吸道及支气管,5—10微米,到达细支气管,1—5微米,才能吸入肺泡,且气压以20磅上下为宜。以前鉴定雾滴直径,均依赖于国外
In recent years, the application of aerosol therapy in respiratory diseases is extremely widespread, such as chronic bronchitis, bronchiectasis, pulmonary abscess, and bronchial asthma, endobronchial tuberculosis and so on, are aerosol inhalation, clinically significant effect . Aerosol droplets of the size of the arrival after inhalation of the site, are generally documented, such as the size of the atomized particles 10-30 microns, up to the upper reaches of the bronchus and bronchus, 5-10 microns, to the bronchioles, 1-5 microns , In order to inhale the alveoli, and the pressure to 20 pounds from top to bottom is appropriate. Previously identified droplet diameter, are dependent on foreign countries